With integrated sample preparation, amplification, detection, and analysis, the BioFire System uses multiplex PCR technology to simultaneously test for a comprehensive grouping of targets in about an hour.
We test at the molecular level to deliver results that are fast, accurate, and comprehensive.
BioFire System instruments run syndromic infectious disease tests. One multiplex assay simultaneously tests for the most common pathogens and antimicrobial resistance genes associated with a particular syndrome.
The BioFire Torch System is the latest advancement in molecular infectious disease diagnostics.
The BioFire 2.0 System enables simplified test ordering, faster turnaround times, and increased accuracy by minimizing manual data entry.
The BioFire System EZ Configuration facilitates rapid near-patient molecular diagnostic testing.
CLIA Certificate of Waiver required to perform testing.
Product not available outside U.S.
The BioFire System offers unmatched ease-of-use with just two minutes of hands-on time and results in about an hour. Training is minimal and the software walks you through the entire molecular testing process.
It takes just three easy steps to get faster disease diagnostic results with BioFire’s multiplex assay technology.
The BioFire FilmArray pouch is a multiplex PCR assay that stores all the necessary reagents for sample preparation, reverse transcription PCR, PCR, and detection in a freeze-dried format. During a test run, the BioFire System extracts and purifies all nucleic acids from the unprocessed sample. Next, it performs nested multiplex PCR in two stages. The first stage includes a single, large volume, multiplexed reaction. The second stage includes individual, single-plex reactions to detect the products from the first stage.
Using endpoint melting curve data, the BioFire System software automatically analyzes the results for each target on the panel. When the run is complete, the software reports whether each pathogen is detected in the sample. This information is printed in an automated response at the end of the test run.
The BioFire System delivers actionable answers in about an hour. Faster results can lead to shorter length-of-stay, fewer downstream diagnostic tests, improved antibiotic stewardship, and better infection control—all of which lead to better patient satisfaction.
Any tech on any shift can use the BioFire System, which requires minimal training and hands-on time to help optimize laboratory productivity 24/7.
One test on the BioFire System simultaneously targets the most likely causes of infection, empowering clinicians to choose the right test, the first time. Results are pathogen-specific, clinically relevant, and can lead to more informed patient management decisions.
BioFire Syndromic Trends provides visual insight into local and regional pathogen circulation trends on-demand. This software feature, available to BioFire customers, makes it possible to monitor infectious disease data in near real-time while preserving patient privacy. De-identified results from a portion of customers running BioFire System tests are sent directly to a cloud-based database that automatically syncs and displays metrics, updating the data daily.
Are you ready to order the BioFire System or want to request a free demo? Click below to take the next step towards faster results with syndromic infectious disease testing.
Product availability varies by country. Consult your bioMérieux representative.